Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Apexigen

  • Apexigen
  • 863 Mitten Road
  • Suite 103
  • Burlingame CA, 94010-1303
  • UNITED STATES

Apexigen is a biotherapeutic development company advancing antibody drug candidates for the treatment of cancer and other serious diseases. The pipeline is led by APX005, an antibody that both exerts direct anti-tumor actions and activates an anti-tumor immune response.  Four other product candidates are currently under development through collaborations. The company’s proprietary rabbit-derived humanized antibody technology platform enables the discovery of a broad diversity of antibodies to a target antigen. This great diversity of antibodies enables the discovery of antibodies with rare or specific biological properties, which may become the next generation of breakthrough therapeutics. Apexigen is employing its strategy to develop innovative bio-therapeutics, advance its product pipeline, and see that important new therapies are made available to patients.

Related To This Company